CIK 0002023658 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Bicara Therapeutics Inc.
Sign in to watch- Ticker
- BCAX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 617-468-4219
- Business address
- 116 HUNTINGTON AVENUE SUITE 703, BOSTON, MA, 02116
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $400,716
- in 1 filing, $401K under 10b5-1 plans
Net −$400,716. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-10-06 | Hyep Ivan Chief Financial Officer | Sale 10b5-1 | −6,514 | $18.17 | $118K | 145,355 |
| 2025-10-06 | Hyep Ivan Chief Financial Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −6,514 | 146,870 | ||
| 2025-10-06 | Cohlhepp Ryan President and COO | Option exercise 10b5-1 | +24,000 | $3.79 | $91K | 245,141 |
| 2025-10-06 | Cohlhepp Ryan President and COO | Sale 10b5-1 | −24,000 | $18.06 | $433K | 221,141 |
| 2025-10-06 | Cohlhepp Ryan President and COO | Sale 10b5-1 | −15,600 | $18.06 | $282K | 205,541 |
| 2025-10-06 | Cohlhepp Ryan President and COO | Option exercise · Stock Option (Right to Buy) 10b5-1 | −24,000 | 173,334 | ||
| 2025-09-29 | Meisner Lara Chief Legal Officer | Option exercise 10b5-1 | +33,807 | $9.24 | $312K | 33,807 |
| 2025-09-29 | Meisner Lara Chief Legal Officer | Sale 10b5-1 | −33,807 | $14.75 | $499K | 0 |
| 2025-09-29 | Meisner Lara Chief Legal Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −33,807 | 101,423 | ||
| 2025-09-15 | Meisner Lara Chief Legal Officer | Option exercise 10b5-1 | +15,829 | $5.45 | $86K | 15,829 |
| 2025-09-15 | Meisner Lara Chief Legal Officer | Sale 10b5-1 | −15,829 | $11.49 | $182K | 0 |
| 2025-09-15 | Meisner Lara Chief Legal Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −6,085 | 54,769 | ||
| 2025-09-15 | Meisner Lara Chief Legal Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −9,744 | 87,699 | ||
| 2025-06-16 | Meisner Lara Chief Legal Officer | Option exercise 10b5-1 | +15,829 | $5.45 | $86K | 15,829 |
| 2025-06-16 | Meisner Lara Chief Legal Officer | Sale 10b5-1 | −15,829 | $10.43 | $165K | 0 |
| 2025-06-16 | Meisner Lara Chief Legal Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −6,085 | 60,854 | ||
| 2025-06-16 | Meisner Lara Chief Legal Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −9,744 | 97,443 | ||
| 2025-06-09 | Haviland Kate Director | Grant or award · Stock Option (Right to Buy) | +23,746 | 23,746 | ||
| 2025-06-09 | Mazumdar-Shaw Kiran Director | Grant or award · Stock Option (Right to Buy) | +23,746 | 23,746 | ||
| 2025-06-09 | POWELL MICHAEL Director | Grant or award · Stock Option (Right to Buy) | +23,746 | 23,746 |
Page 11 of 14 · 276 trades